• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 10 of 100
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
LeadershipAstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By AFPNovember 7, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
LifestyleDanish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness
By Ryan HoggNovember 4, 2024
Jo Natauri’s Invidia Capital seeks $850 million for first fund
FinanceJo Natauri’s Invidia Capital seeks $850 million for first fund
By Luisa BeltranOctober 31, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
RetailBritish pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
A hand is seen holding Ozempic.
HealthNovo’s main Ozempic plant cited for quality lapses by FDA
By Madison Muller and BloombergOctober 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
HealthTop aging expert says these 4 FDA-approved drugs hold promise for extending life
By Alexa MikhailOctober 29, 2024
Sanofi profit lifted by early vaccine sales, dupixent growth
FinanceSanofi profit lifted by early vaccine sales, dupixent growth
By Ashleigh Furlong, Tim Loh and BloombergOctober 25, 2024
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
CommentaryAs activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
HealthPneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By Lindsey LeakeOctober 22, 2024
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
LeadershipHow Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
By John KellOctober 22, 2024
France's Prime Minister Michel Barnier speaking to reporters.
HealthFrench government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue
By Jurgen Hecker, Tom Barfield and AFPOctober 22, 2024
Anne Wojcicki, chief executive officer and co-founder of 23andMe
Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024
The world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
CommentaryThe world needs innovative antiviral drugs—but market incentives won’t align until it’s too late, Germany’s ‘head of challenges’ warns
By Jano CostardOctober 16, 2024
Walgreens to close 1,200 stores over next three years
HealthWalgreens to close 1,200 stores over next three years
By Chris MorrisOctober 15, 2024
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
RetailFrance’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By Jurgen Hecker and AFPOctober 15, 2024
1...
  • 8
  • 9
  • 10
  • 11
  • 12
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right awayplaceholder alt text
By Orianna Rosa RoyleMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.